May 22, 2024
Boston: “According to the latest BCC Research study, the demand for Antibiotics: Technologies and Global Markets should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2%.”
This report covers the latest progress in chemical compounds and the latest drugs, except those aimed at control of the vector or symptomatic treatment. It emphasizes antibiotics, tests their market potential, segmentation of competition landscapes and markets based on the type of product (such as cell wall inhibitors, protein inhibitors, DNA, and other inhibitors), administrative pathways (oral and topical), and geographical regions (including North America, Europe, Asia-Pacific, South America, and the Middle East and Africa). The analysis covers key countries in these regions and provides insight into market dynamics, pricing, the impact of COVID-19, and the regulatory environment. Market forecasts till 2027 and market share assessment of key players deepen the report and provide pharmaceutical industry stakeholders with a comprehensive view.
Antibiotic resistance is a growing problem worldwide, causing over 1.27 million deaths annually and costing the U.S. $4.6 billion each year. From 2000 to 2018, antibiotic use surged by 46%, especially in regions like North Africa, the Middle East, and South Asia. The COVID-19 pandemic worsened the situation, with antibiotics often misused to treat the virus. This highlights the urgent need for better stewardship and innovative approaches to tackle antibiotic resistance globally.
To learn more about "Antibiotics: Technology and Global Market Report", please click here for more information.
Key Drivers of the Antibiotics: Technologies and Global Markets
Growth Driven by Antibiotics: The global demand for antibiotics is rising due to their essential role in treating bacterial infections across various medical sectors. Factors such as increasing infectious disease prevalence, drug-resistant bacteria emergence, and pharmaceutical research investment drive this growth.
Rising Elder Population and Infection Rate: As the global population ages, there is a surge in infections among the elderly due to weakened immune systems. This demographic trend boosts the need for antibiotics to manage age-related health conditions.
Increasing Hospital-acquired Infections: Hospital-acquired infections (HAIs) are a significant concern, driving demand for antibiotics to treat and prevent their spread within healthcare facilities.
Improved Awareness: Greater awareness about responsible antibiotic use among healthcare professionals and the public promotes sustainable usage and combats antibiotic resistance.
Request a Sample Copy of the Antibiotics: Technologies and Global Markets Report.
Report Synopsis
|
Report Metrics |
Details |
|
Base year considered |
2021s |
|
Forecast Period considered |
2022-2027 |
|
Base year market size |
$10.4 billion |
|
Market Size Forecast |
$19.5 billion |
|
Growth Rate |
CAGR of 11.0% for the forecast period of 2023-2028 |
|
Segment Covered |
Product, Route of Administration |
|
Regions covered |
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
|
Countries covered |
U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Japan, China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, Indonesia, Brazil, Argentina, Chile, Colombia, Peru, GCC countries, South Africa, Tukey, Egypt, Nigeria, Kenya |
|
Key Market Drivers |
|
Segmentation Analysis:
Product Types Segmentation Analysis:
Cell Wall Inhibitors: These antibiotics disrupt bacterial cell walls, stopping bacterial growth. Examples: penicillins, cephalosporins, glycopeptides (e.g., vancomycin).
Protein Inhibitors: They interfere with bacterial protein synthesis, hindering their function. Examples: tetracyclines, macrolides (e.g., erythromycin), aminoglycosides (e.g., gentamicin).
DNA Inhibitors: These antibiotics disrupt bacterial DNA processes, hampering survival. Examples: fluoroquinolones (e.g., ciprofloxacin), sulfonamides.
Other Types of Inhibitors: Unique mechanisms include inhibiting RNA synthesis or metabolic pathways. Examples: linezolid, and trimethoprim.
Routes of Administration Segmentation Analysis:
Oral Antibiotics: Taken by mouth for mild to moderate infections. Examples: amoxicillin, doxycycline, azithromycin.
Topical Antibiotics: Applied to skin or mucous membranes for localized infections. Examples: antibiotic creams, ointments, and eye drops.
Other Routes: Includes IV administration for severe infections or when oral is not feasible.
This Antibiotics: Technologies and Global Markets Report contains comprehensive information and analysis covering the following key questions:
1. What is the projected market size and growth rate of the Antibiotics Market?
2. What are the key factors driving the growth of the Antibiotics Market?
3. What segments are covered in the Antibiotics market?
4. By Type, which segment will dominate the market by the end of 2027?
5. Which region has the highest market share in the Antibiotics Market?
Some of the Key Market Players Are:
Directly Purchase a copy of the report with BCC Research.
For further information or to make a purchase, please get in touch with info@bccresearch.com.
Antibiotics: Technologies and Global Markets( PHM025F )
Publish Date: May 2023
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.